|
J Biol Chem, Vol. 273, Issue 16, 9951-9958, April 17, 1998
Characterization of V3 Loop-Pseudomonas Exotoxin
Chimeras
CANDIDATE VACCINES FOR HUMAN IMMUNODEFICIENCY VIRUS-1
David J.
FitzGerald ,
Charlotte M.
Fryling ,
Marian L.
McKee ,
JoAnn C.
Vennari¶,
Terri
Wrin¶,
Mary E. M.
Cromwell ,
Ann L.
Daugherty , and
Randall J.
Mrsny
From the Biotherapy Section, Laboratory of Molecular
Biology, Division of Basic Science, NCI, National Institutes of Health,
Bethesda, Maryland 20892-4255 and ¶ Cell Banking and Drug
Delivery/Biology, Pharmaceutical Research and Development, Genentech
Inc., South San Francisco, California 94080-4990
To develop a candidate vaccine for human
immunodeficiency virus, type 1 (HIV-1), chimeric proteins were
constructed by inserting sequences derived from the V3 loop of gp120
into a nontoxic form of Pseudomonas exotoxin (PE). Inserts
of 14 or 26 amino acids, constrained by a disulfide bond, were
introduced between domains II and III of PE. V3 loop-toxin proteins
expressed in Escherichia coli and corresponding to either
MN (subtype B) or Thai (subtype E) strains, were recognized by
strain-specific monoclonal anti-gp120 antibodies. When loop sequences
were introduced into an enzymatically active form of the toxin, there
was no loss of toxin-mediated cell killing, suggesting that these
sequences were co-transported to the cytosol. Sera from rabbits
injected with nontoxic PE-V3 loop chimeras were reactive for
strain-specific gp120s in Western blots, immunocapture assays,
enzyme-linked immunosorbent assays, and neutralized HIV-1 infectivity.
Since toxin vectors were designed to receive oligonucleotide duplexes
encoding any V3 loop sequence, this approach should allow for the
production of V3 loop-toxin chimeras corresponding to multiple HIV
isolates.
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. C. Hsieh, D. M. Tham, W. Feng, F. Huang, S. Embaie, K. Liu, D. Dean, R. Hertle, D. J. FitzGerald, and R. J. Mrsny
Intranasal Immunization Strategy To Impede Pilin-Mediated Binding of Pseudomonas aeruginosa to Airway Epithelial Cells
Infect. Immun.,
November 1, 2005;
73(11):
7705 - 7717.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Hertle, R. Mrsny, and D. J. Fitzgerald
Dual-Function Vaccine for Pseudomonas aeruginosa: Characterization of Chimeric Exotoxin A-Pilin Protein
Infect. Immun.,
November 1, 2001;
69(11):
6962 - 6969.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|